A platform for ultrasensitive and selective multiplexed marker protein assay toward early-stage cancer diagnosis

ISSN： 1743-5889

Source： Nanomedicine, Vol.2, Iss.1, 2007-02, pp. : 79-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of the Onco type DX™ 21-Gene Assay to Guide Adjuvant Decision Making in Early-Stage Breast Cancer

By Conlin Alison K. Seidman Andrew D.

Molecular Diagnosis & Therapy, Vol. 11, Iss. 6, 2007-01 ,pp. : 355-360

Adis International

Access to resources Recommend Favorite

Matrix Metalloproteinase Activity in Early-Stage Lung Cancer

Oncology Research and Treatment, Vol. 36, Iss. 5, 2013-04 ,pp. : 256-259

Karger

Access to resources Recommend Favorite

Surgical Treatment of Early-Stage Cervical Cancer

Oncology Research and Treatment, Vol. 39, Iss. 9, 2016-08 ,pp. : 508-514

Karger

Access to resources Recommend Favorite

Neutrophil–lymphocyte ratio is a reliable predictive marker for early‐stage diabetic nephropathy

CLINICAL ENDOCRINOLOGY, Vol. 82, Iss. 2, 2015-02 ,pp. : 229-233

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative effectiveness of aggressive versus nonaggressive treatment among men with early‐stage prostate cancer and differing comorbid disease burdens at diagnosis

CANCER, Vol. 120, Iss. 16, 2014-08 ,pp. : 2432-2439

John Wiley & Sons Inc

Access to resources Recommend Favorite